Table 2 Observed and expected prevalence of co-occurring pairs of diseases involving CKD in the whole study population (N = 2252)
From: Chronic kidney disease in the context of multimorbidity patterns: the role of physical performance
Co-occurring pairs | Cases n | Observed % | Expected % | Obs/Exp ratio | Adjusted for age and sex | Fully adjusted | |||
|---|---|---|---|---|---|---|---|---|---|
OR | 95%CI | OR | 95%CI | ||||||
CKD | Hypertension | 1224 | 54.4 | 50.7 | 1.07 | 2.30 | 1.87–2.82 | 1.90 | 1.53–2.36 |
CKD | Vision impairment | 880 | 39.1 | 38.1 | 1.03 | 1.25 | 1.04–1.50 | 1.06 | 0.87–1.29 |
CKD | Hearing impairment | 822 | 36.5 | 34.2 | 1.07 | 1.37 | 1.15–1.64 | 1.20 | 0.98–1.46 |
CKD | Osteoporosis | 449 | 19.9 | 20.1 | 0.99 | 1.02 | 0.83–1.25 | 0.95 | 0.76–1.18 |
CKD | Diabetes | 420 | 18.7 | 16.6 | 1.12 | 1.63 | 1.31–2.03 | 1.22 | 0.97–1.55 |
Anemia | CKD | 388 | 17.2 | 13.9 | 1.24 | 2.26 | 1.75–2.92 | 1.95 | 1.49–2.54 |
CHF | CKD | 305 | 13.5 | 10.9 | 1.24 | 2.47 | 1.86–3.29 | 1.73 | 1.27–2.36 |
Cancer | CKD | 282 | 12.5 | 11.4 | 1.10 | 1.36 | 1.06–1.75 | 1.27 | 0.98–1.64 |
Atrial fibrillation | CKD | 276 | 12.3 | 10.1 | 1.22 | 2.07 | 1.55–2.75 | 1.57 | 1.15–2.13 |
CKD | Depression | 212 | 9.4 | 9.3 | 1.02 | 1.06 | 0.81–1.37 | 0.93 | 0.71–1.23 |
CKD | COPD | 202 | 9.0 | 7.8 | 1.15 | 1.58 | 1.16–2.14 | 1.26 | 0.91–1.74 |
CKD | Myocardial infarction | 182 | 8.1 | 6.4 | 1.27 | 2.46 | 1.68–3.61 | 1.75 | 1.17–2.62 |
CKD | TIA | 136 | 6.0 | 5.7 | 1.05 | 1.07 | 0.77–1.49 | 0.88 | 0.62–1.24 |
CKD | Cognitive impairment | 120 | 5.3 | 4.8 | 1.10 | 1.15 | 0.80–1.67 | 1.06 | 0.72–1.56 |
CKD | Stroke | 98 | 4.4 | 3.8 | 1.13 | 1.37 | 0.90–2.07 | 1.11 | 0.72–1.72 |
Angina | CKD | 94 | 4.2 | 3.9 | 1.07 | 1.17 | 0.79–1.74 | 0.72 | 0.46–1.11 |
Asthma | CKD | 81 | 3.6 | 3.6 | 0.99 | 1.03 | 0.69–1.52 | 0.85 | 0.56–1.28 |
CKD | Hip fracture | 65 | 2.9 | 3.3 | 0.89 | 0.57 | 0.38–0.86 | 0.59 | 0.38–0.91 |
CKD | Parkinson | 31 | 1.4 | 1.3 | 1.04 | 0.94 | 0.49–1.82 | 0.83 | 0.42–1.67 |